We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-24.98%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$489M
AUM Growth
-$335M
Cap. Flow
-$147M
Cap. Flow %
-29.98%
Top 10 Hldgs %
77.53%
Holding
27
New
Increased
4
Reduced
15
Closed
2

Sector Composition

Rank Sector Weight
1 Healthcare 87.19%
2 Consumer Staples 0.27%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
$87.8M 17.96%
542,589
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
$55M 11.24%
3,485,078
-87,885
-2% -$1.41M
QDEL icon
3
QuidelOrtho
QDEL
$1.14B
$53.2M 10.88%
2,816,284
-79,524
-3% -$1.7M
CMRX
4
DELISTED
Chimerix, Inc.
CMRX
$37.7M 7.71%
986,421
-39,500
-4% -$1.95M
OPK icon
5
Opko Health
OPK
$1.25B
$33.6M 6.88%
4,000,000
-959,335
-19% -$12.7M
MZOR
6
DELISTED
Mazor Robotics Ltd.
MZOR
$27.5M 5.62%
2,492,911
+53,674
+2% +$692K
PGEN icon
7
Precigen
PGEN
$1.97B
$25.6M 5.24%
812,121
-72,270
-8% -$3.53M
ACOR
8
DELISTED
Acorda Therapeutics
ACOR
$21.6M 4.42%
6,799
TSRO
9
DELISTED
TESARO, Inc.
TSRO
$19.8M 4.05%
494,250
+1,250
+0.3% +$68.3K
VRML
10
DELISTED
Vermillion, Inc.
VRML
$17.2M 3.53%
8,624,225
+512,043
+6% +$1.03M
HNSN
11
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$16.9M 3.45%
4,491,816
-3
-0% -$20
AGEN
12
Agenus
AGEN
$275M
$15M 3.06%
165,619
-16,761
-9% -$2.48M
ARAY icon
13
Accuray
ARAY
$29M
$14.4M 2.95%
2,884,305
-292,533
-9% -$1.88M
PACB icon
14
Pacific Biosciences
PACB
$432M
$11.8M 2.42%
3,236,161
-5,600
-0.2% -$27.4K
AMRN
15
Amarin Corp
AMRN
$293M
$11.7M 2.4%
303,844
+44,633
+17% +$2.03M
WBMD
16
DELISTED
WebMD Health Corp.
WBMD
$9.49M 1.94%
238,103
BIOL
17
DELISTED
Biolase, Inc.
BIOL
$9.43M 1.93%
838
TTHI
18
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$7.1M 1.45%
3,966,022
-897,892
-18% -$1.91M
CFRX
19
DELISTED
ContraFect Corporation
CFRX
$5.26M 1.08%
1,478
RGLS
20
DELISTED
Regulus Therapeutics
RGLS
$2.45M 0.5%
3,121
-3,061
-50% -$3.14M
BIIB icon
21
Biogen
BIIB
$30.4B
$2.25M 0.46%
7,723
YTEN
22
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$1.32M 0.27%
100
-20
-17% -$513K
TCRT icon
23
Alaunos Therapeutics
TCRT
$4.64M
$1.21M 0.25%
895
-719
-45% -$1.19M
VANI icon
24
Vivani Medical
VANI
$113M
$1.21M 0.25%
8,477
-273
-3% -$75.8K
THOR
25
DELISTED
THORATEC CORPORATION
THOR
$316K 0.06%
5,000
-1,224,600
-100% -$72.7M

Similar funds

Oracle Investment Management's Q3 2015 Portfolio in Review

As of Q3 2015, Oracle Investment Management held 27 positions worth $489M, down 41% from $824M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Oracle Investment Management withdrew a net $147M in Q3 2015, closing 2 positions and reducing 15 holdings. Its most notable exit was Ladenburg Thalmann Financial Services Inc, an estimated $210K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 76% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Oracle Investment Management added an estimated $2.03M to Amarin Corp.

  • Oracle Investment Management added most to Amarin Corp in Q3 2015, an estimated $2.03M increase.
  • Oracle Investment Management's biggest Q3 2015 reduction was THORATEC CORPORATION, cutting an estimated $72.7M.
  • Oracle Investment Management fully exited Ladenburg Thalmann Financial Services Inc in Q3 2015, selling an estimated $210K.
  • Oracle Investment Management's ten largest holdings make up 78% of its $489M portfolio in Q3 2015.
  • Oracle Investment Management opened 0 new positions and closed 2 in Q3 2015.
  • Oracle Investment Management's portfolio value fell 41% quarter-over-quarter to $489M.

Based on Oracle Investment Management's 13F filing for Q3 2015, filed 16 Nov 2015.